![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](sj2227contents.gif)
Acta Cryst. (2007). E63, o1529-o1531 [ doi:10.1107/S1600536807008951 ]
Abstract: In the structure of the title compound, C25H29N6O+·Cl-·1.69H2O, the irbesartan cation adopts tautomeric form A. The structure is stabilized by systems of hydrogen bonds forming ribbons along the ac diagonal, interlinked by sets of weaker hydrogen bonds involving the solvent water.
Online 2 March 2007
Copyright © International Union of Crystallography
IUCr Webmaster